Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate.
Prostate ductal development is initiated by androgen-dependent signals in fetal urogenital sinus (UGS) mesenchyme that stimulate prostatic bud formation in UGS epithelium. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, 5 microg/kg maternal dose) inhibited ventral and dorsolateral but not anterior prostatic budding. We sought to determine which stage of budding, specification or initiation, was inhibited. Ventral prostatic bud formation was maximally inhibited when TCDD exposure spanned E15.5-16.5 and dorsolateral prostatic bud formation when it spanned E14.5-15.5. Because ventral and dorsolateral buds are specified at these times, TCDD impaired bud specification. We hypothesized that TCDD inhibited ventral bud specification by forming a continuous smooth muscle barrier between UGS mesenchyme and epithelium in the ventral prostatic UGS region, blocking mesenchymal-epithelial signaling, but no such barrier was found. We hypothesized that increased aryl hydrocarbon receptor (AHR) signaling in ventral and dorsolateral UGS increased their sensitivity to TCDD, but levels of AHR nuclear translocator (ARNT) protein, Ahr mRNA, and AHR-dependent gene expression were not higher than in anterior UGS where budding was unaffected. However, we identified overlapping expression of Ahr, ARNT, and AHR-induced transcripts in the periprostatic mesenchyme which intimately contacts UGS epithelium where buds are specified. This was considered the putative TCDD site of action in the UGS for inhibition of ventral and dorsolateral prostatic bud specification. Thus, hyperactivation of AHR signaling appears to disrupt dorsoventral patterning of the UGS, reprogramming where prostatic buds are specified, and prostate lobes are formed. Disrupted axial patterning provides a new paradigm for understanding how in utero TCDD exposure causes ventral prostate agenesis and may shed light on how TCDD impairs development of other organs.
Vezina
Chad M
CM
School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, USA.
Allgeier
Sarah Hicks
SH
Moore
Robert W
RW
Lin
Tien-Min
TM
Bemis
Jeffrey C
JC
Hardin
Heather A
HA
Gasiewicz
Thomas A
TA
Peterson
Richard E
RE
D000818:Animals; D001483:Base Sequence; D019521:Body Patterning / Q000187:drug effects*; D017931:DNA Primers; D004305:Dose-Response Relationship, Drug; D005260:Female; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008855:Microscopy, Electron, Scanning; D000072317:Polychlorinated Dibenzodioxins / Q000633:toxicity*; D011247:Pregnancy; D011467:Prostate / Q000187:drug effects* / Q000196:embryology
D017931:DNA Primers; D000072317:Polychlorinated Dibenzodioxins
Toxicol Sci. 2003 Nov;76(1):171-81
12944588
Mech Dev. 1998 Apr;73(1):117-23
9545558
Toxicol Appl Pharmacol. 2002 Oct 1;184(1):57-66
12392969
Toxicol Sci. 2003 Dec;76(2):427-36
14514962
Curr Top Dev Biol. 2008;81:1-63
18023723
J Exp Zool. 1978 Aug;205(2):181-93
681909
Development. 2006 May;133(9):1611-24
16613830
Toxicol Appl Pharmacol. 2004 Apr 1;196(1):149-55
15050416
Epithelial Cell Biol. 1993 Apr;2(2):66-78
8353595
Dev Biol. 2003 Sep 1;261(1):39-54
12941620
Semin Cell Dev Biol. 2007 Apr;18(2):237-44
17336109
Differentiation. 2008 Jul;76(6):728-35
18557758
J Urol. 2004 Jul;172(1):365-8
15201812
Toxicol Sci. 2002 May;67(1):63-74
11961217
Toxicol Appl Pharmacol. 1998 Jul;151(1):33-44
9705885
Science. 1993 Jul 9;261(5118):215-8
8392225
Toxicol Appl Pharmacol. 2006 May 1;212(3):200-11
16125745
J Endocrinol. 1987 Jul;114(1):131-7
3655602
Toxicol Sci. 2004 Jun;79(2):360-9
15056816
Toxicol Sci. 2002 Sep;69(1):202-9
12215675
Trends Genet. 1996 Jul;12(7):253-7
8763496
Toxicol Appl Pharmacol. 2007 Oct 1;224(1):29-38
17655899
Curr Top Dev Biol. 2008;81:341-71
18023734
Development. 2002 Apr;129(8):1905-12
11934856
Biol Reprod. 1986 Jun;34(5):961-71
3730488
Toxicol Sci. 2002 Aug;68(2):479-87
12151645
Toxicol Sci. 2002 Dec;70(2):227-37
12441367
J Mammary Gland Biol Neoplasia. 2006 Oct;11(3-4):187-203
17111222
Development. 1999 Aug;126(16):3693-701
10409514
J Toxicol Environ Health A. 2001 Oct 26;64(4):327-42
11693491
Science. 1992 May 22;256(5060):1193-5
1317062